Sarepta Therapeutics to Present at the UBS Biopharma Conference

Rhea-AI Summary

Sarepta Therapeutics, Inc. will participate in a fireside chat at the UBS Biopharma Conference on November 9, 2023. The presentation will be webcast live and archived on Sarepta's website for 90 days.

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will participate in a fireside chat at the UBS Biopharma Conference on Thursday, Nov. 9, 2023 at 9:00 a.m. E.T. The fireside chat will be held at the Fontainebleau Miami Beach in Miami Beach, Fla.

The presentation will be webcast live under the Events & Presentations section of the investor relations section of Sarepta’s website at https://investorrelations.sarepta.com/events-presentations and will be archived there following the presentation for 90 days. Please connect to Sarepta's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

About Sarepta Therapeutics

Sarepta is on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing. For more information, please visit www.sarepta.com or follow us on Twitter, LinkedIn, Instagram and Facebook.

Internet Posting of Information

We routinely post information that may be important to investors in the 'For Investors' section of our website at www.sarepta.com. We encourage investors and potential investors to consult our website regularly for important information about us.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231102269533/en/

Investor Contact:

Ian Estepan, 617-274-4052

iestepan@sarepta.com

Media Contact:

Tracy Sorrentino, 617-301-8566

tsorrentino@sarepta.com

Source: Sarepta Therapeutics, Inc.

FAQ

When will Sarepta Therapeutics participate in the UBS Biopharma Conference?

Sarepta Therapeutics will participate in the UBS Biopharma Conference on Thursday, November 9, 2023.

Where will the fireside chat be held?

The fireside chat will be held at the Fontainebleau Miami Beach in Miami Beach, Florida.

Where can I watch the presentation?

The presentation will be webcast live on Sarepta's website under the Events & Presentations section of the investor relations section.

Will the presentation be available after the event?

Yes, the presentation will be archived on Sarepta's website for 90 days.

Is there any software download required to watch the webcast?

Please connect to Sarepta's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.